BioTime Inc. buy melinda
Start price
26.06.17
/
50%
€2.84
Target price
26.12.17
€3.40
Performance (%)
-32.36%
End price
26.12.17
€1.92
Summary
This prediction ended on 26.12.17 with a price of €1.92. Massive losses of -32.36% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioTime Inc. | - | - | - | - |
| iShares Core DAX® | 0.300% | 4.701% | 4.537% | 51.554% |
| iShares Nasdaq 100 | 0.434% | 12.255% | 31.983% | 98.287% |
| iShares Nikkei 225® | 1.633% | 12.616% | 43.258% | 69.873% |
| iShares S&P 500 | 0.566% | 7.786% | 23.475% | 69.791% |
Comments by melinda for this prediction
In the thread BioTime Inc. diskutieren
zu folgen
AST-OPC1 - SCiStar
Zervikale Rückenmark
(Laufzeit überschritten)


